CD28 and rheumatoid arthritis: Of note, in the context of inflammatory diseases such as RA and GPA, CMV-driven expansions of CD4+CD28− T cells are accentuated compared to otherwise healthy individuals, which will increase the potential for tissue damage (11, 32).